Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Sir Aziz Sheikh OBE gave his inaugural lecture at the University of Oxford, sharing his vision for transforming global health care through data, innovation and equity.

Collage of Aziz's inaugural lecture

On 29 April, Professor Sir Aziz Sheikh OBE gave his inaugural lecture, marking his appointment as Nuffield Professor of Primary Care Health Sciences and Head of the Nuffield Department of Primary Care Health Sciences at the University of Oxford. 

Titled ‘Catalysing the Data-enabled Transformation of Health - Globally’, the lecture took place at Oxford’s historic Examination Schools, and was hosted by the University’s Vice-Chancellor, Professor Irene Tracey CBE. She introduced the event by celebrating the Department’s practical impact on health care, its values driven and inclusive culture and the significance of Professor Sheikh’s leadership at a time of global change and opportunity.

Bringing together colleagues, collaborators and health leaders from across the world of medicine, the event offered a chance to reflect on Professor Sheikh’s journey in medicine and research - to hear his vision for transforming health care through data, innovation and inclusivity. The lecture traced Professor Sheikh's personal and professional path - from his early life in Karachi, Pakistan, to growing up in East London, training in medicine at UCL, and building an academic career focused on improving health care. 

Apparent throughout was the strong influence that family, community, and an unwavering belief in equity have had for Professor Sheikh. He spoke movingly about the people and experiences that have shaped his work, sharing candid insights from his formative years and reflecting openly on his journey, one he likened to a rikshaw ride - not always comfortable or straight forward, but survivable and lively, nonetheless.

 

Read the full story on the Nuffield Department of Primary Care Health Sciences website.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.